title: Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506.
authors.affiliation: Division of Liver Transplantation, Mount Sinai Medical Center, New York, New York.
authors.forename: R M
authors.initials: RM
authors.lastname: Jindal
authors.forename: I
authors.initials: I
authors.lastname: Popescu
authors.forename: S
authors.initials: S
authors.lastname: Emre
authors.forename: M E
authors.initials: ME
authors.lastname: Schwartz
authors.forename: P
authors.initials: P
authors.lastname: Boccagni
authors.forename: P
authors.initials: P
authors.lastname: Meneses
authors.forename: E
authors.initials: E
authors.lastname: Mor
authors.forename: P
authors.initials: P
authors.lastname: Sheiner
authors.forename: C M
authors.initials: CM
authors.lastname: Miller
mesh_terms: D000328:Adult; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D005919:Glomerular Filtration Rate; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007262:Infusions, Intravenous; D008055:Lipids / Q000097:blood*; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D008055:Lipids; D016572:Cyclosporine; D016559:Tacrolimus